Detection of clinical progression through plasma ctDNA in metastatic melanoma patients: a comparison to radiological progression

BACKGROUND: The validity of circulating tumour DNA (ctDNA) as an indicator of disease progression compared to medical imaging in patients with metastatic melanoma requires detailed evaluation. METHODS: Here, we carried out a retrospective ctDNA analysis of 108 plasma samples collected at the time of...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsavela, Gabriela, McEvoy, Ashleigh C., Pereira, Michelle R., Reid, Anna L., Al-Ogaili, Zeyad, Warburton, Lydia, Khattak, Muhammad A., Abed, Afaf, Meniawy, Tarek M., Millward, Michael, Ziman, Melanie R., Calapre, Leslie, Gray, Elin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810871/
https://www.ncbi.nlm.nih.gov/pubmed/34373567
http://dx.doi.org/10.1038/s41416-021-01507-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810871/
https://www.ncbi.nlm.nih.gov/pubmed/34373567
http://dx.doi.org/10.1038/s41416-021-01507-6

Ejemplares similares